Subscribe To
Senti Bio to Present at the SVB Securities Global Biopharma Conference
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company innovating next-generation cell and gene therapies using its proprietary Gene Circuit technology platform, today announced that Tim Lu, MD, PhD, Senti’s Co-Founder and CEO, will present at the SVB Securities Global Biopharma Conference. Event details: […] The post Senti Bio to Present at the SVB Securities Global Biopharma Conference appeared first on ForexT...
Read More
Posted: Feb 1 2023, 21:05
Author Name: forextv
Views: 111773